|
1
|
Mallick NP and Gokal R: Haemodialysis.
Lancet (London, England). 353:737–742. 1999.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Radosa CG, Radosa JC, Weiss N, Schmidt C,
Werth S, Hofmockel T, Plodeck V, Gatzweiler C, Laniado M and
Hoffmann RT: Endovascular creation of an arteriovenous fistula
(endoAVF) for hemodialysis access: First results. Cardiovasc
Intervent Radiol. 40:1545–1551. 2017.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Gh K, Mhs M, Ravari H, Daliri M, Hoseini L
and Nateghi M: Primary patency rate of native AV fistula: Long term
follow up. Int J Clin Exp Med. 5:173–178. 2012.PubMed/NCBI
|
|
4
|
Dixon BS: Why don't fistulas mature?
Kidney Int. 70:1413–1422. 2006.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Sullivan KL, Besarab A, Bonn J, Shapiro
MJ, Gardiner GA Jr and Moritz MJ: Hemodynamics of failing dialysis
grafts. Radiology. 186:867–872. 1993.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Bashar K, Conlon PJ, Kheirelseid EA,
Aherne T, Walsh SR and Leahy A: Arteriovenous fistula in dialysis
patients: Factors implicated in early and late AVF maturation
failure. Surgeon. 14:294–300. 2016.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Langer S, Kokozidou M, Heiss C, Kranz J,
Kessler T, Paulus N, Krüger T, Jacobs MJ, Lente C and Koeppel TA:
Chronic kidney disease aggravates arteriovenous fistula damage in
rats. Kidney Int. 78:1312–1321. 2010.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Low EL, Baker AH and Bradshaw AC: TGFβ,
smooth muscle cells and coronary artery disease: A review. Cell
Signal. 53:90–101. 2019.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Yue Y, Ma K, Li Z and Wang Z: Angiotensin
II type 1 receptor-associated protein regulates carotid intimal
hyperplasia through controlling apoptosis of vascular smooth muscle
cells. Biochem Biophys Res Commun. 495:2030–2037. 2018.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Zhao J, Jourd'heuil FL, Xue M, Conti D,
Lopez-Soler RI, Ginnan R, Asif A, Singer HA, Jourd'heuil D and Long
X: Dual function for mature vascular smooth muscle cells during
arteriovenous fistula remodeling. J Am Heart Assoc.
30(e004891)2017.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Liu C, Su T, Li F, Li L, Qin X, Pan W,
Feng F, Chen F, Liao D and Chen L: PI3K/Akt signaling transduction
pathway is involved in rat vascular smooth muscle cell viability
induced by apelin-13. Acta Biochim Biophys Sin (Shanghai).
42:396–402. 2010.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Gerthoffer WT: Mechanisms of vascular
smooth muscle cell migration. Circ Res. 100:607–621.
2007.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Park ES, Kang SI, Yoo KD, Lee MY, Yoo HS,
Hong JT, Shin HS, Kim B and Yun YP: Camptothecin inhibits
platelet-derived growth factor-BB-induced viability of rat aortic
vascular smooth muscle cells through inhibition of PI3K/Akt
signaling pathway. Exp Cell Res. 319:982–991. 2013.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Fang H, Yang S, Luo Y, Zhang C, Rao Y, Liu
R, Feng Y and Yu J: Notoginsenoside R1 inhibits vascular smooth
muscle cell viability, migration and neointimal hyperplasia through
PI3K/Akt signaling. Sci Rep. 8(7595)2018.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Ao H, Feng W and Peng C: Hydroxysafflor
yellow A: A promising therapeutic agent for a broad spectrum of
diseases. Evid Based Complement Alternat Med.
2018(8259280)2018.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Bai Y, Lu P, Han C, Yu C, Chen M, He F, Yi
D and Wu L: Hydroxysafflor yellow A (HSYA) from flowers of
carthamus tinctorius L. and its vasodilatation effects on pulmonary
artery. Molecules. 17:14918–14927. 2012.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Chen L, Xiang Y, Kong L, Zhang X, Sun B,
Wei X and Liu H: Hydroxysafflor yellow A protects against cerebral
ischemia-reperfusion injury by anti-apoptotic effect through
PI3K/Akt/GSK3β pathway in rat. Neurochem Res. 38:2268–2275.
2013.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Xiao J, Lv Y, Jin F, Liu Y, Ma Y, Xiong Y,
Liu L, Zhang S, Sun Y, Tipoe GL, et al: LncRNA HANR promotes
tumorigenesis and increase of chemoresistance in hepatocellular
carcinoma. Cell Physiol Biochem. 43:1926–1938. 2017.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Ye F, Wang J, Meng W, Qian J and Jin M:
Proteomic investigation of effects of hydroxysafflor yellow A in
oxidized low-density lipoprotein-induced endothelial injury. Sci
Rep. 7(17981)2017.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Jiang M, Zhou LY, Xu N and An Q:
Hydroxysafflor yellow A inhibited lipopolysaccharide-induced
non-small cell lung cancer cell proliferation, migration, and
invasion by suppressing the PI3K/AKT/mTOR and ERK/MAPK signaling
pathways. Thorac Cancer. 10:1319–1333. 2019.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Song Y, Long L, Zhang N and Liu Y:
Inhibitory effects of hydroxysafflor yellow A on PDGF-BB-induced
viability and migration of vascular smooth muscle cells via
mediating akt signaling. Mol Med Rep. 10:1555–1560. 2014.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Yang G, Zhou X, Chen T, Deng Y, Yu D, Pan
S and Song Y: Hydroxysafflor yellow A inhibits
lipopolysaccharide-induced viability and migration of vascular
smooth muscle cells via toll-like receptor-4 pathway. Int J Clin
Exp Med. 8:5295–5302. 2015.PubMed/NCBI
|
|
23
|
Chen J, Shi W, Xu Y, Zhang H and Chen B:
Hirudin prevents vascular endothelial cell apoptosis and
permeability enhancement induced by the serum from rat with chronic
renal failure through inhibiting RhoA/ROCK signaling pathway. Drug
Dev Res 20: doi:10.1002, 2020.
|
|
24
|
Zhang G, Cui G, Tong S and Cao Q:
Salvianolic acid A alleviates the renal damage in rats with chronic
renal failure1. Acta Cir Bras. 34(e201900204)2019.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Xue L, Pan Z, Yin Q, Zhang P, Zhang J and
Qi W: Liraglutide promotes autophagy by regulating the AMPK/mTOR
pathway in a rat remnant kidney model of chronic renal failure. Int
Urol Nephrol. 51:2305–2313. 2019.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Ngai HH, Sit WH and Wan JM: The
nephroprotective effects of the herbal medicine preparation, WH30+,
on the chemical-induced acute and chronic renal failure in rats. Am
J Chin Med. 33:491–500. 2005.PubMed/NCBI View Article : Google Scholar
|
|
27
|
Chen S, Ma J, Zhu H, Deng S, Gu M and Qu
S: Hydroxysafflor yellow A attenuates high glucose-induced human
umbilical vein endothelial cell dysfunction. Hum Exp Toxicol.
38:685–693. 2019.PubMed/NCBI View Article : Google Scholar
|
|
28
|
Sun L, Xu YW, Han J, Xiao C, Cao SS, Liang
H and Cheng Y: Hydroxysafflor yellow A shows protection against
PPAR γ inactivation in nitrosative neurons. Oxid Med Cell Longev.
2018(9101740)2018.PubMed/NCBI View Article : Google Scholar
|
|
29
|
Chen Z, Liu L, Liu Y, Wang S, Zhang S,
Dong R, Xu M, Ma Y, Wang J, Zhang Q and Wei P: Hydroxysafflor
yellow A induces autophagy in human liver cancer cells by
regulating beclin 1 and ERK expression. Exp Ther Med. 19:2989–2996.
2020.PubMed/NCBI View Article : Google Scholar
|
|
30
|
Guo X, Zheng M, Pan R, Zang B, Gao J, Ma H
and Jin M: Hydroxysafflor yellow A (HSYA) targets the
platelet-activating factor (PAF) receptor and inhibits human
bronchial smooth muscle activation induced by PAF. Food Funct.
10:4661–4673. 2019.PubMed/NCBI View Article : Google Scholar
|
|
31
|
Bahnson ES, Koo N, Cantu-Medellin N, Tsui
AY, Havelka GE, Vercammen JM, Jiang Q, Kelley EE and Kibbe MR:
Nitric oxide inhibits neointimal hyperplasia following vascular
injury via differential, cell-specific modulation of SOD-1 in the
arterial wall. Nitric Oxide. 44:8–17. 2015.PubMed/NCBI View Article : Google Scholar
|
|
32
|
Rothuizen TC, Wong C, Quax PH, van
Zonneveld AJ, Rabelink TJ and Rotmans JI: Arteriovenous access
failure: More than just intimal hyperplasia? Nephrol Dial
Transplant. 28:1085–1092. 2013.PubMed/NCBI View Article : Google Scholar
|
|
33
|
Rotmans JI, Pasterkamp G, Verhagen HJ,
Pattynama PM, Blankestijn PJ and Stroes ES: Hemodialysis access
graft failure: Time to revisit an unmet clinical need? J Nephrol.
18:9–20. 2005.PubMed/NCBI
|
|
34
|
Kokubo T, Ishikawa N, Uchida H, Chasnoff
SE, Xie X, Mathew S, Hruska KA and Choi ET: CKD accelerates
development of neointimal hyperplasia in arteriovenous fistulas. J
Am Soc Nephrol. 20:1236–1245. 2009.PubMed/NCBI View Article : Google Scholar
|
|
35
|
Marx SO, Totary-Jain H and Marks AR:
Vascular smooth muscle cell viability in restenosis. Circ
Cardiovasc Interv. 4:104–111. 2011.PubMed/NCBI View Article : Google Scholar
|
|
36
|
Rzucidlo EM, Martin KA and Powell RJ:
Regulation of vascular smooth muscle cell differentiation. J Vas
Surg. 45 (Suppl A):A25–A32. 2007.PubMed/NCBI View Article : Google Scholar
|
|
37
|
Dember LM, Beck GJ, Allon M, Delmez JA,
Dixon BS, Greenberg A, Himmelfarb J, Vazquez MA, Gassman JJ, Greene
T, et al: Effect of clopidogrel on early failure of arteriovenous
fistulas for hemodialysis: A randomized controlled trial. JAMA.
299:2164–2171. 2008.PubMed/NCBI View Article : Google Scholar
|
|
38
|
Al-Jaishi AA, Oliver MJ, Thomas SM, Lok
CE, Zhang JC, Garg AX, Kosa SD, Quinn RR and Moist LM: Patency
rates of the arteriovenous fistula for hemodialysis: A systematic
review and meta-analysis. Am J Kidney Dis. 63:464–478.
2014.PubMed/NCBI View Article : Google Scholar
|
|
39
|
Tang F, Liu M, Zeng O, Tan W, Long J, Liu
S, Yang J and Chu C: Gefitinib-coated balloon inhibits the
excessive hyperplasia of intima after vascular injuries through
PI3K/AKT pathway. Technol Health Care. 27:331–343. 2019.PubMed/NCBI View Article : Google Scholar
|
|
40
|
Zhu J, Chen X, Wang H and Yan Q: Catalpol
protects mice against renal ischemia/reperfusion injury via
suppressing PI3K/Akt-eNOS signaling and inflammation. Int J Clin
Exp Med. 8:2038–2044. 2015.PubMed/NCBI
|
|
41
|
Hu S, Zhang Y, Zhang M, Guo Y, Yang P,
Zhang S, Simsekyilmaz S, Xu JF, Li J, Xiang X, et al: Aloperine
protects mice against ischemia-reperfusion (IR)-induced renal
injury by regulating PI3K/AKT/mTOR signaling and AP-1 activity. Mol
Med. 21:912–923. 2016.PubMed/NCBI View Article : Google Scholar
|
|
42
|
Potočnjak I and Domitrović R: Carvacrol
attenuates acute kidney injury induced by cisplatin through
suppression of ERK and PI3K/Akt activation. Food Chem Tox.
98:251–261. 2016.PubMed/NCBI View Article : Google Scholar
|
|
43
|
Ma SK, Joo SY, Kim CS, Choi JS, Bae EH,
Lee J and Kim SW: Increased hosphorylation of PI3K/Akt/mTOR in the
obstructed kidney of rats with unilateral ureteral obstruction.
Chonnam Med J. 49:108–112. 2013.PubMed/NCBI View Article : Google Scholar
|
|
44
|
Ahanchi SS, Tsihlis ND and Kibbe MR: The
role of nitric oxide in the pathophysiology of intimal hyperplasia.
J Vasc Surg. 45 Suppl A:A64–A73. 2007.PubMed/NCBI View Article : Google Scholar
|
|
45
|
Hogg ME, Varu VN, Vavra AK, Popowich DA,
Banerjee MN, Martinez J, Jiang Q, Saavedra JE, Keefer LK and Kibbe
MR: Effect of nitric oxide on neointimal hyperplasia based on sex
and hormone status. Free Rad Biol Med. 50:1065–1074.
2011.PubMed/NCBI View Article : Google Scholar
|
|
46
|
Chen R, Chen T, Wang T, Dai X, Meng K,
Zhang S, Jiang D, Wang Y, Zhou K, Geng T, et al: Tongmai Yangxin
pill reduces myocardial no-reflow by regulating apoptosis and
activating PI3K/Akt/eNOS pathway. J Ethnopharmacol.
261(113069)2020.PubMed/NCBI View Article : Google Scholar
|
